A healthcare worker stands during the first stage of COVID-19 vaccination plan, which aims to inoculate teachers, military personnel, firefighters and police officers, among other non medical essential workers, at a vaccination center in Antel Arena, Montevideo, Uruguay March 1, 2021. REUTERS/Mariana Greif

Uruguay on Tuesday released real-world data on the impact of Sinovac Biotech’s (SVA.O) COVID-19 vaccine among its population that showed it was over 90% effective in preventing intensive care admissions and deaths.

The shot reduced deaths by 95% and intensive care admissions by 92%, and also showed 61% efficacy in cutting coronavirus infections, the government said.

A total of 795,684 people

Read More At Article Source | Article Attribution